23 March, 2026
18:30 CET | Online
Attendance is FREE, but registration in advance is required.
Join us for the next monthly broadcast of Respiratory News Live, taking place on 23 March, 2026 live on the ERS Respiratory Channel.
Hosted by European Respiratory Journal Chief Editor Prof. James Chalmers, each Respiratory News Live broadcast presents respiratory news from the past 30 days. Broadcasts cover the hottest topics, the newest therapies, breaking news, and the most significant scientific developments. It will also highlight any developments on the horizon.
Each event also features:
- A live audience Q&A;
- Paper in focus: the author of a particularly interesting or notable publication from the previous 30 days provides a short summary of their work;
- Guest interview - each month, a respiratory expert is invited to take part in a live interview focused on a hot topic or recent development from the previous 30 days
Watch the replay from Respiratory News Live - February
Target audience:
- Pulmonologists
- Clinicians
- Respiratory researchers
- Basic and translational scientists
- Epidemiologists
- Thoracic surgeons
- Thoracic oncologists
- Respiratory paediatricians
- Allied healthcare professionals
- Patient representatives
About the event host: Prof. James Chalmers
Prof. James Chalmers MBChB, PhD is the Rhodes Chair of Experimental Therapeutics at the University of Oxford, and serves as a clinician-scientist in respiratory medicine, and an honorary consultant.
Prof. Chalmers is also Chief Editor of the European Respiratory Journal. His clinical work focuses on difficult respiratory infections and bronchiectasis, and his research portfolio encompasses immunology, microbiome, mucociliary clearance, and translational experimental medicine in lung disease, including bronchiectasis, COPD and acute respiratory infections.
He has published more than 500 peer-reviewed manuscripts, and chaired major European respiratory guideline panels on topics such as bronchiectasis, COPD, and COVID-19. He also chairs the EMBARC European Bronchiectasis Network, leads international EMBARC studies and trials, and is a lead author on key bronchiectasis publications.